Product description

Therapeutic Area: Nervous System
  • EU DMF available
  • US DMF no. 20581 available

Indication: anti-epileptic or anti-seizure drug. It is indicated for treatment of partial onset seizures or primary generalized tonic-clonic seizures and adjunctive therapy in patients 6 years of age and older with seizures associated with Lennox-Gastaut syndrome. It is also indicated for the prophylaxis of migraine headache in adults.

brhrbrC12H21NO8S
Read more

Specifications

Categories Contract Services - Contract ServicesContract Manufacturing
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from Poland
Measured In g; Kgs

More products from ZF Polpharma SA

View all our products (32)

Products from other suppliers